Abstract
Extracellular vesicles (EVs) are diverse nanoparticles with large heterogeneity in size and molecular composition. Although this heterogeneity provides high diagnostic value for liquid biopsy and confers many exploitable functions for therapeutic applications in cancer detection, wound healing and neurodegenerative and cardiovascular diseases, it has also impeded their clinical translation—hence heterogeneity acts as a double-edged sword. Here we review the impact of subpopulation heterogeneity on EV function and identify key cornerstones for addressing heterogeneity in the context of modern analytical platforms with single-particle resolution. We outline concrete steps towards the identification of key active biomolecules that determine EV mechanisms of action across different EV subtypes. We describe how such knowledge could accelerate EV-based therapies and engineering approaches for mimetic artificial nanovesicle formulations. This approach blunts one edge of the sword, leaving only a single razor-sharp edge on which EV heterogeneity can be exploited for therapeutic applications across many diseases.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Yáñez-Mó, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).
Midekessa, G. et al. Zeta potential of extracellular vesicles: toward understanding the attributes that determine colloidal stability. ACS Omega 5, 16701–16710 (2020).
Zhu, X. et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J. Extracell. Vesicles 6, 1324730 (2017).
Elsharkasy, O. M. et al. Extracellular vesicles as drug delivery systems: why and how? Adv. Drug Deliv. Rev. 159, 332–343 (2020).
Parada, N., Romero-Trujillo, A., Georges, N. & Alcayaga-Miranda, F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J. Adv. Res. 31, 61–74 (2021).
Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329–335 (2015). This study provides direct evidence that EVs from tumour cells exhibit specific tropism towards target organs, which is one of the most promising features of EVs compared with synthetic nanocarriers intended for clinical applications.
Choi, H. et al. Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng. Regener. Med. https://doi.org/10.1007/s13770-021-00361-0 (2021).
Wiklander, O. P. B. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles https://doi.org/10.3402/jev.v4.26316 (2015).
Sung, B. H. & Weaver, A. M. Exosome secretion promotes chemotaxis of cancer cells. Cell Adhes. Migr. 11, 187–195 (2017).
Kriebel, P. W. et al. Extracellular vesicles direct migration by synthesizing and releasing chemotactic signals. J. Cell Biol. 217, 2891–2910 (2018).
Hosseini, R. et al. The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells. Mol. Cancer 20, 83 (2021).
Yuan, P. et al. Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 axis. Front. Cell Dev. Biol. https://doi.org/10.3389/fcell.2021.601600 (2021).
Huang, J., Ding, Z., Luo, Q. & Xu, W. Cancer cell-derived exosomes promote cell proliferation and inhibit cell apoptosis of both normal lung fibroblasts and non-small cell lung cancer cell through delivering alpha-smooth muscle actin. Am. J. Transl. Res. 11, 1711–1723 (2019).
Matsumoto, Y. et al. Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines. Cancer Sci. 111, 4348–4358 (2020).
Harmati, M. et al. Small extracellular vesicles convey the stress-induced adaptive responses of melanoma cells. Sci. Rep. 9, 15329 (2019).
Mathieu, M., Martin-Jaular, L., Lavieu, G. & Théry, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9–17 (2019).
Bonsergent, E. et al. Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells. Nat. Commun. 12, 1864 (2021).
Walker, S. et al. Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics 9, 8001–8017 (2019).
Shi, Y., van der Meel, R., Chen, X. & Lammers, T. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics 10, 7921–7924 (2020).
Jakubec, M. et al. Plasma-derived exosome-like vesicles are enriched in lyso-phospholipids and pass the blood–brain barrier. PLoS ONE 15, e0232442 (2020).
Morad, G. et al. Tumor-derived extracellular vesicles breach the intact blood–brain barrier via transcytosis. ACS Nano 13, 13853–13865 (2019). This research provides a precise description of how tumour-derived EVs manage to breach the formidable BBB, revealing the role of transcytosis and the endothelial recycling endocytic pathway during the process.
Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G. & Karamanos, Y. Targeting and brossing the blood–brain barrier with extracellular vesicles. Cells 9, 851 (2020).
Whiteside, T. L. Exosomes carrying immunoinhibitory proteins and their role in cancer. Clin. Exp. Immunol. 189, 259–267 (2017).
Yang, E. et al. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduction Targeted Ther. 5, 242 (2020).
Kuriyama, N., Yoshioka, Y., Kikuchi, S., Azuma, N. & Ochiya, T. Extracellular vesicles are key regulators of tumor neovasculature. Front. Cell Dev. Biol. https://doi.org/10.3389/fcell.2020.611039 (2020).
Richter, M., Vader, P. & Fuhrmann, G. Approaches to surface engineering of extracellular vesicles. Adv. Drug Deliv. Rev. 173, 416–426 (2021).
Kim, H. et al. Engineered extracellular vesicles and their mimetics for clinical translation. Methods 177, 80–94 (2020).
Lener, T. et al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. J. Extracell. Vesicles 4, 30087 (2015).
Nguyen, V. V. T., Witwer, K. W., Verhaar, M. C., Strunk, D. & Balkom, B. W. M. Functional assays to assess the therapeutic potential of extracellular vesicles. J. Extracell. Vesicles 10, e12033 (2020). This study addresses the urgent need for standardized and predictive assays to gauge the therapeutic potential of EVs, ensuring consistent therapeutic efficacy and batch-to-batch reproducibility.
Liang, X. et al. Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models. J. Extracell. Vesicles 11, e12248 (2022).
Xu, M. et al. Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance. ACS Nano 17, 20825–20849 (2023).
Sharma, S., LeClaire, M., Wohlschlegel, J. & Gimzewski, J. Impact of isolation methods on the biophysical heterogeneity of single extracellular vesicles. Sci. Rep. 10, 13327 (2020).
Caponnetto, F. et al. Size-dependent cellular uptake of exosomes. Nanomedicine 13, 1011–1020 (2017).
Bobrie, A., Colombo, M., Krumeich, S., Raposo, G. & Théry, C. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J. Extracell. Vesicles 1, 18397 (2012).
Mazouzi, Y. et al. Biosensing extracellular vesicle subpopulations in neurodegenerative disease conditions. ACS Sens. 7, 1657–1665 (2022).
Mitchell, M. I. et al. Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV‐CATCHER): a customizable purification assay designed for small‐RNA biomarker identification and evaluation of circulating small‐EVs. J. Extracell. Vesicles 10, e12110 (2021).
Kang, Y. et al. Isolation and profiling of circulating tumor‐associated exosomes using extracellular vesicular lipid–protein binding affinity based microfluidic device. Small 15, 1903600 (2019).
Zhang, H. et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332–343 (2018). This study underscores the heterogeneity of EV populations, introduces the creative use of AF4, two distinct EV sizes and the previously unreported ‘exomeres’.
Kowal, J. et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl Acad. Sci. USA 113, E968–E977 (2016).
Lázaro-Ibáñez, E. et al. DNA analysis of low- and high-density fractions defines heterogeneous subpopulations of small extracellular vesicles based on their DNA cargo and topology. J. Extracell. Vesicles 8, 1656993 (2019).
Lee, S.-S. et al. A novel population of extracellular vesicles smaller than exosomes promotes cell proliferation. Cell Commun. Signal. 17, 95 (2019).
Emelyanov, A. et al. Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid. PLoS ONE 15, e0227949 (2020).
Arraud, N. et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J. Thromb. Haemost. 12, 614–627 (2014).
van der Pol, E., Welsh, J. A. & Nieuwland, R. Minimum information to report about a flow cytometry experiment on extracellular vesicles: communication from the ISTH SSC subcommittee on vascular biology. J. Thromb. Haemost. 20, 245–251 (2022).
Jeppesen, D. K. et al. Reassessment of exosome composition. Cell https://doi.org/10.1016/j.cell.2019.02.029 (2019).
Pfrieger, F. W. & Vitale, N. Cholesterol and the journey of extracellular vesicles. J. Lipid Res. 59, 2255–2261 (2018).
Mathieu, M. et al. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat. Commun. 12, 4389 (2021).
Zendrini, A. et al. On the surface-to-bulk partition of proteins in extracellular vesicles. Colloids Surf. B Biointerfaces 218, 112728 (2022).
Zhang, Q. et al. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets. Nat. Cell Biol. 23, 1240–1254 (2021).
Anand, S., Samuel, M. & Mathivanan, S. in New Frontiers: Extracellular Vesicles Vol. 97 (eds Mathivanan, S. et al.) 89–97 (Springer, 2021).
Wang, G. et al. Tumour extracellular vesicles and particles induce liver metabolic dysfunction. Nature 618, 374–382 (2023).
Jahnke, K. & Staufer, O. Membranes on the move: the functional role of the extracellular vesicle membrane for contact‐dependent cellular signalling. J. Extracell. Vesicles 13, e12436 (2024).
Mizenko, R. R. et al. Tetraspanins are unevenly distributed across single extracellular vesicles and bias sensitivity to multiplexed cancer biomarkers. J. Nanobiotechnol. 19, 250 (2021).
Ferguson, S., Yang, K. S. & Weissleder, R. Single extracellular vesicle analysis for early cancer detection. Trends Mol. Med. 28, 681–692 (2022).
Mol, E. A., Goumans, M.-J., Doevendans, P. A., Sluijter, J. P. G. & Vader, P. Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation. Nanomedicine 13, 2061–2065 (2017).
Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).
Martel, R., Shen, M. L., DeCorwin-Martin, P., De Araujo, L. O. F. & Juncker, D. Extracellular vesicle antibody microarray for multiplexed inner and outer protein analysis. ACS Sens. 7, 3817–3828 (2022).
Ko, J., Wang, Y., Sheng, K., Weitz, D. A. & Weissleder, R. Sequencing-based protein analysis of single extracellular vesicles. ACS Nano 15, 5631–5638 (2021).
Sariano, P. A. et al. Convection and extracellular matrix binding control interstitial transport of extracellular vesicles. J. Extracell. Vesicles 12, e12323 (2023).
Welsh, J. A. et al. A compendium of single extracellular vesicle flow cytometry. J. Extracell. Vesicles 12, e12299 (2023).
Deng, F. et al. Single-particle interferometric reflectance imaging characterization of individual extracellular vesicles and population dynamics. J. Vis. Exp. https://doi.org/10.3791/62988 (2022).
Cimorelli, M., Nieuwland, R., Varga, Z. & Van Der Pol, E. Standardized procedure to measure the size distribution of extracellular vesicles together with other particles in biofluids with microfluidic resistive pulse sensing. PLoS ONE 16, e0249603 (2021).
McNamara, R. P. et al. Imaging of surface microdomains on individual extracellular vesicles in 3-D. J. Extracell. Vesicles 11, e12191 (2022). Using advanced direct stochastic optical reconstruction microscopy, this work reports the imaging of spatial microdomains on single EVs, uncovering a previously unappreciated level of structural intricacy and heterogeneity.
Saftics, A. et al. Single Extracellular VEsicle Nanoscopy. J. Extracell. Vesicles 12, 12346 (2023). Using SRM, this study introduces an innovative assay that provides in-depth insights into the physical, chemical and morphological characteristics of individual EVs in the context of discerning disease-associated and organ-associated EV subtypes.
Höög, J. L. & Lötvall, J. Diversity of extracellular vesicles in human ejaculates revealed by cryo-electron microscopy. J. Extracell. Vesicles 4, 28680 (2015).
Musante, L. et al. Rigorous characterization of urinary extracellular vesicles (uEVs) in the low centrifugation pellet - a neglected source for uEVs. Sci. Rep. 10, 3701 (2020).
Paolini, L. et al. Fourier-transform infrared (FT-IR) spectroscopy fingerprints subpopulations of extracellular vesicles of different sizes and cellular origin. J. Extracell. Vesicles 9, 1741174 (2020).
Kwon, Y. & Park, J. Methods to analyze extracellular vesicles at single particle level. Micro Nano Syst. Lett. 10, 14 (2022).
Bachurski, D. et al. Extracellular vesicle measurements with nanoparticle tracking analysis – an accuracy and repeatability comparison between NanoSight NS300 and ZetaView. J. Extracell. Vesicles 8, 1596016 (2019).
Enciso-Martinez, A. et al. Synchronized Rayleigh and Raman scattering for the characterization of single optically trapped extracellular vesicles. Nanomedicine 24, 102109 (2020).
Jung, M. K. & Mun, J. Y. Sample preparation and imaging of exosomes by transmission electron microscopy. J. Vis. Exp. https://doi.org/10.3791/56482 (2018).
Andronico, L. A. et al. Sizing extracellular vesicles using membrane dyes and a single molecule-sensitive flow analyzer. Anal. Chem. 93, 5897–5905 (2021).
Morales, R.-T. T. & Ko, J. Future of digital assays to resolve clinical heterogeneity of single extracellular vesicles. ACS Nano 16, 11619–11645 (2022).
Welsh, J. A., Jones, J. C. & Tang, V. A. Fluorescence and light scatter calibration allow comparisons of small particle data in standard units across different flow cytometry platforms and detector settings. Cytometry A 97, 592–601 (2020).
Nieuwland, R., Siljander, P. R.-M., Falcón-Pérez, J. M. & Witwer, K. W. Reproducibility of extracellular vesicle research. Eur. J. Cell Biol. 101, 151226 (2022).
Kashkanova, A. D., Blessing, M., Gemeinhardt, A., Soulat, D. & Sandoghdar, V. Precision size and refractive index analysis of weakly scattering nanoparticles in polydispersions. Nat. Methods 19, 586–593 (2022).
Kanwar, S. S., Dunlay, C. J., Simeone, D. M. & Nagrath, S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14, 1891–1900 (2014).
Kamerkar, S. et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546, 498–503 (2017).
Roerig, J. et al. A focus on critical aspects of uptake and transport of milk-derived extracellular vesicles across the Caco-2 intestinal barrier model. Eur. J. Pharm. Biopharm. 166, 61–74 (2021).
Wolf, M. et al. A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation. J. Extracell. Vesicles 11, e12207 (2022).
Banks, W. A. et al. Transport of extracellular vesicles across the blood–brain barrier: brain pharmacokinetics and effects of inflammation. Int. J. Mol. Sci. 21, 4407 (2020).
Kumar, P. et al. Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes. FASEB J. 33, 5836–5849 (2019).
Yadid, M. et al. Endothelial extracellular vesicles contain protective proteins and rescue ischemia–reperfusion injury in a human heart-on-chip. Sci. Transl. Med. 12, eaax8005 (2020).
You, B. et al. Extracellular vesicles rich in HAX1 promote angiogenesis by modulating ITGB6 translation. J. Extracell. Vesicles 11, e12221 (2022).
Fan, J., Xu, G., Chang, Z., Zhu, L. & Yao, J. miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathway. Clin. Sci. 134, 807–825 (2020).
Choi, J. S. et al. Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and provide biochemical cues for skeletal muscle regeneration. J. Control. Release 222, 107–115 (2016).
Yang, J., Zhang, X., Chen, X., Wang, L. & Yang, G. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol. Ther. Nucleic Acids 7, 278–287 (2017).
Kennedy, T. L., Russell, A. J. & Riley, P. Experimental limitations of extracellular vesicle-based therapies for the treatment of myocardial infarction. Trends Cardiovasc. Med. 31, 405–415 (2021).
Reiner, A. T. et al. Concise Review: Developing best-practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl. Med. 6, 1730–1739 (2017).
Paolini, L. et al. Large-scale production of extracellular vesicles: report on the “massivEVs” ISEV workshop. J. Extracell. Biol. 1, e63 (2022).
Witwer, K. W. et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J. Extracell. Vesicles 8, 1609206 (2019).
Gimona, M. et al. Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy 23, 373–380 (2021). This road-map article on mesenchymal stromal/stem cells (MSCs) presents an analysis within the context of therapeutic medicine, emphasizing the potential of small EVs over traditional cellular MSC products, with a focus on the intricacies and challenges in quality control and consistent potency.
Poupardin, R., Wolf, M. & Strunk, D. Adherence to minimal experimental requirements for defining extracellular vesicles and their functions. Adv. Drug Deliv. Rev. 176, 113872 (2021).
Lötvall, J. et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles 3, 26913 (2014).
Théry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).
EV-TRACK Consortium et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 14, 228–232 (2017).
Otero-Ortega, L. et al. Low dose of extracellular vesicles identified that promote recovery after ischemic stroke. Stem Cell Res. Ther. 11, 70 (2020).
Sjöqvist, S. et al. Exosomes derived from clinical-grade oral mucosal epithelial cell sheets promote wound healing. J. Extracell. Vesicles 8, 1565264 (2019).
Karttunen, J. et al. Effect of cell culture media on extracellular vesicle secretion from mesenchymal stromal cells and neurons. Eur. J. Cell Biol. 101, 151270 (2022).
Salmond, N., Khanna, K., Owen, G. R. & Williams, K. C. Nanoscale flow cytometry for immunophenotyping and quantitating extracellular vesicles in blood plasma. Nanoscale 13, 2012–2025 (2021).
Basu, J. & Ludlow, J. W. Cell-based therapeutic products: potency assay development and application. Regen. Med. 9, 497–512 (2014).
Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products (Food and Drug Administration, 2011).
Ko, S. Y. et al. The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells. J. Extracell. Vesicles 12, 12318 (2023). This study reveals a fundamental discovery: the glycoproteins CD147 and CD98 uniquely characterize specific EV subpopulations, fundamentally different from the traditional tetraspanin-positive EVs, providing an enhanced specificity in distinguishing cancerous origins.
Sung, B. H. et al. A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells. Nat. Commun. 11, 2092 (2020).
Lee, E. J., Choi, Y., Lee, H. J., Hwang, D. W. & Lee, D. S. Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies. J. Nanobiotechnol. 20, 198 (2022).
Hao, Q. et al. Mesenchymal stem cell-derived extracellular cesicles decrease lung injury in mice. J. Immunol. 203, 1961–1972 (2019).
Kulaj, K. et al. Adipocyte-derived extracellular vesicles increase insulin secretion through transport of insulinotropic protein cargo. Nat. Commun. 14, 709 (2023).
Xie, F. et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat. Commun. 13, 4461 (2022).
Baumgart, T., Hunt, G., Farkas, E. R., Webb, W. W. & Feigenson, G. W. Fluorescence probe partitioning between Lo/Ld phases in lipid membranes. Biochim. Biophys. Acta Biomembr. 1768, 2182–2194 (2007).
Tertel, T. et al. Imaging flow cytometry challenges the usefulness of classically used extracellular vesicle labeling dyes and qualifies the novel dye Exoria for the labeling of mesenchymal stromal cell–extracellular vesicle preparations. Cytotherapy 24, 619–628 (2022).
Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).
Zhang, X. et al. Proteomic analysis of MSC-derived apoptotic vesicles identifies Fas inheritance to ameliorate haemophilia a via activating platelet functions. J. Extracell. Vesicles 11, e12240 (2022).
Campos-Mora, M. et al. Neuropilin-1 is present on Foxp3+ T regulatory cell-derived small extracellular vesicles and mediates immunity against skin transplantation. J. Extracell. Vesicles 11, e12237 (2022).
Collino, F. et al. AKI recovery induced by mesenchymal stromal cell-derived extracellular vesicles carrying microRNAs. J. Am. Soc. Nephrol. 26, 2349–2360 (2015).
Scalise, M., Pochini, L., Giangregorio, N., Tonazzi, A. & Indiveri, C. Proteoliposomes as tool for sssaying membrane transporter functions and interactions with xenobiotics. Pharmaceutics 5, 472–497 (2013).
Sejwal, K. et al. Proteoliposomes – a system to study membrane proteins under buffer gradients by cryo-EM. Nanotechnol. Rev. 6, 57–74 (2017).
Shapira, S. et al. A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond. EMBO Mol. Med. 14, e15997 (2022).
Gwak, H., Park, S., Yu, H., Hyun, K.-A. & Jung, H.-I. A modular microfluidic platform for serial enrichment and harvest of pure extracellular vesicles. Analyst 147, 1117–1127 (2022).
Bordanaba-Florit, G., Royo, F., Kruglik, S. G. & Falcón-Pérez, J. M. Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles. Nat. Protoc. https://doi.org/10.1038/s41596-021-00551-z (2021).
Hromada, C., Mühleder, S., Grillari, J., Redl, H. & Holnthoner, W. Endothelial extracellular vesicles—promises and challenges. Front. Physiol. 8, 275 (2017).
Yang, Z. et al. Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation. J. Control. Release 243, 160–171 (2016).
Ramasubramanian, L., Kumar, P. & Wang, A. Engineering extracellular vesicles as nanotherapeutics for regenerative medicine. Biomolecules 10, 48 (2020).
Jang, S. C. et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7, 7698–7710 (2013).
Jo, W. et al. Large-scale generation of cell-derived nanovesicles. Nanoscale 6, 12056–12064 (2014).
Bozzuto, G. & Molinari, A. Liposomes as nanomedical devices. Int. J. Nanomed. 10, 975–999 (2015).
Akbarzadeh, A. et al. Liposome: classification, preparation, and applications. Nanoscale Res. Lett. 8, 102 (2013).
Patil, Y. P. & Jadhav, S. Novel methods for liposome preparation. Chem. Phys. Lipids 177, 8–18 (2014).
Lapinski, M. M., Castro-Forero, A., Greiner, A. J., Ofoli, R. Y. & Blanchard, G. J. Comparison of liposomes formed by sonication and extrusion: rotational and translational diffusion of an embedded chromophore. Langmuir 23, 11677–11683 (2007).
Large, D. E., Abdelmessih, R. G., Fink, E. A. & Auguste, D. T. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv. Drug Deliv. Rev. 176, 113851 (2021).
Jahn, A., Vreeland, W. N., DeVoe, D. L., Locascio, L. E. & Gaitan, M. Microfluidic directed formation of liposomes of controlled size. Langmuir 23, 6289–6293 (2007).
Carugo, D., Bottaro, E., Owen, J., Stride, E. & Nastruzzi, C. Liposome production by microfluidics: potential and limiting factors. Sci. Rep. 6, 25876 (2016).
Genç, R., Ortiz, M. & O′Sullivan, C. K. Curvature-tuned preparation of nanoliposomes. Langmuir 25, 12604–12613 (2009).
Piffoux, M., Silva, A. K. A., Wilhelm, C., Gazeau, F. & Tareste, D. Modification of extracellular vesicles by fusion with liposomes for the design of personalized biogenic drug delivery systems. ACS Nano 12, 6830–6842 (2018).
Kuntsche, J., Decker, C. & Fahr, A. Analysis of liposomes using asymmetrical flow field-flow fractionation: separation conditions and drug/lipid recovery. J. Sep. Sci. 35, 1993–2001 (2012).
Larsen, J., Hatzakis, N. S. & Stamou, D. Observation of inhomogeneity in the lipid composition of individual nanoscale liposomes. J. Am. Chem. Soc. 133, 10685–10687 (2011).
Moulahoum, H., Ghorbanizamani, F., Zihnioglu, F. & Timur, S. Surface biomodification of liposomes and polymersomes for efficient targeted drug delivery. Bioconjug. Chem. 32, 1491–1502 (2021).
Staufer, O. et al. Bottom-up assembly of biomedical relevant fully synthetic extracellular vesicles. Sci. Adv. 7, eabg6666 (2021). This research introduces an exciting synthetic approach based on mimetic EVs with defined compositions, a promising avenue for clinical applications and a platform for dissecting the intricacies of EV signalling mechanisms.
Cheng, K. et al. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nat. Commun. 12, 2041 (2021).
Rodríguez, D. A. & Vader, P. Extracellular vesicle-based hybrid systems for advanced drug delivery. Pharmaceutics 14, 267 (2022).
Morales-Kastresana, A. et al. Labeling extracellular vesicles for nanoscale flow cytometry. Sci. Rep. 7, 1878 (2017).
Melling, G. E. et al. Confocal microscopy analysis reveals that only a small proportion of extracellular vesicles are successfully labelled with commonly utilised staining methods. Sci. Rep. 12, 262 (2022).
Acknowledgements
We acknowledge support from the National Institutes of Health, including R01CA241666, R01EB033389, R01EB034279 and R35GM142788. R.R.M. was supported by F31NS120590. N.L. was supported by a funded training grant program (T32HL007013) of the National Heart, Lung, and Blood Institute. T.H. was supported by an NDSEG Fellowship. A.A. was supported by UC Davis MCB T32. This work was supported in part by the UC Davis Comprehensive Cancer Center’s Women’s Cancer Care & Research (WeCARE) program.
Author information
Authors and Affiliations
Contributions
R.P.C and R.R.M. wrote the paper and prepared the figures. R.P.C., R.R.M., A.W., C.T. and S.C.G. conceptualized the work. B.T.B., N.L., T.H., A.A., A.W., C.T. and S.C.G. draughted sections of the paper and edited them. N.L. and R.R.M. performed experiments.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Nanotechnology thanks Edwin van der Pol for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Carney, R.P., Mizenko, R.R., Bozkurt, B.T. et al. Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications. Nat. Nanotechnol. 20, 14–25 (2025). https://doi.org/10.1038/s41565-024-01774-3
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41565-024-01774-3
This article is cited by
-
Extracellular particles: emerging insights into central nervous system diseases
Journal of Nanobiotechnology (2025)
-
Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment
Molecular Cancer (2025)
-
Extracellular vesicles in tumor immunity: mechanisms and novel insights
Molecular Cancer (2025)
-
Prominosomes - a particular class of extracellular vesicles containing prominin-1/CD133?
Journal of Nanobiotechnology (2025)
-
Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
Stem Cell Research & Therapy (2025)